SMR Biotech Co., Ltd.   Report issue

Government
Founded: Shanghai China
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2016
NCT02560740
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

acetaminophen (tylenol) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1